Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I–associated neuroimmunological disease
Yoshihisa Yamano, … , Dragan A. Maric, Steven Jacobson
Yoshihisa Yamano, … , Dragan A. Maric, Steven Jacobson
Published May 2, 2005
Citation Information: J Clin Invest. 2005;115(5):1361-1368. https://doi.org/10.1172/JCI23913.
View: Text | PDF
Article Immunology

Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I–associated neuroimmunological disease

  • Text
  • PDF
Abstract

CD4+CD25+ Tregs are important in the maintenance of immunological self tolerance and in the prevention of autoimmune diseases. As the CD4+CD25+ T cell population in patients with human T cell lymphotropic virus type I–associated (HTLV-I–associated) myelopathy/tropical spastic paraparesis (HAM/TSP) has been shown to be a major reservoir for this virus, it was of interest to determine whether the frequency and function of CD4+CD25+ Tregs in HAM/TSP patients might be affected. In these cells, both mRNA and protein expression of the forkhead transcription factor Foxp3, a specific marker of Tregs, were lower than those in CD4+CD25+ T cells from healthy individuals. The virus-encoded transactivating HTLV-I tax gene was demonstrated to have a direct inhibitory effect on Foxp3 expression and function of CD4+CD25+ T cells. This is the first report to our knowledge demonstrating the role of a specific viral gene product (HTLV-I Tax) on the expression of genes associated with Tregs (in particular, foxp3) resulting in inhibition of Treg function. These results suggest that direct human retroviral infection of CD4+CD25+ T cells may be associated with the pathogenesis of HTLV-I–associated neurologic disease.

Authors

Yoshihisa Yamano, Norihiro Takenouchi, Hong-Chuan Li, Utano Tomaru, Karen Yao, Christian W. Grant, Dragan A. Maric, Steven Jacobson

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Lack of regulatory function in CD4+CD25+ T cells from HAM/TSP patients. ...
Lack of regulatory function in CD4+CD25+ T cells from HAM/TSP patients. A total of 1 × 105 CD4+CD25– T cells/well from HDs were labeled with CFSE. They were cultured for 6 days in the culture medium in the absence or presence of 2.5 μg/ml anti-CD3 antibody (top 2 panels). They were also cultured for 6 days in 2.5 μg/ml anti-CD3 antibody added to culture medium with 1 × 105 irradiated allogeneic CD4+CD25+ T cells from HDs or with 1 × 105 irradiated CD4+CD25+ T cells from HAM/TSP patients (bottom 2 panels). The data indicate that regulatory function in CD4+CD25+ T cells from HAM/TSP patients is reduced in comparison with that in CD4+CD25+ T cells from HDs. Failure of CD4+CD25+ T cells to suppress lymphoproliferation of activated HD cells was observed in separate experiments with cells from 4 HAM/TSP patients, while suppression of activated HD cell proliferation by allogeneic HD CD4+CD25+ T cells from 2 HDs was demonstrated.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts